Join
Live feed
·
INSIDERFilingvia Quantisnow
NeuroBo Pharmaceuticals Inc. logo

Glickman Mark A was granted 5,051 shares, increasing direct ownership by 108% to 9,740 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
NRBO· NeuroBo Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NRBO (NeuroBo Pharmaceuticals Inc.) and more on Quantisnow.